US FDA and CMS launch parallel review pilot for medical devices
This article was originally published in SRA
Executive Summary
The US Food and Drug Administration and the Centers for Medicare & Medicaid Services (CMS) have launched a voluntary pilot programme in which the agencies will conduct concurrent reviews of medical devices for FDA approval and Medicare coverage, in a bid to expedite patient access to products1,2.